Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06300450 · ClinicalTrials.gov registry record · NA
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
A NA study of Peripheral Artery Disease and Dyslipidemias, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06300450 is a NA study of Peripheral Artery Disease and Dyslipidemias that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 400 participants, above the 119-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (236% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06300450, a NA study of Peripheral Artery Disease and Dyslipidemias, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-center, 400-patient, randomized controlled trial assesses the impact of a patient- and provider-facing EPIC Best Practice Advisory (BPA; alert-based computerized decision support tool) to increase guideline-directed utilization of statin and statin-alternative oral LDL-C lowering therapies in patients with PAD who are not being prescribed LDL-C-lowering therapy.
Conditions Studied
Interventions
- BEHAVIORAL Computer Alert
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06300450
The ClinicalTrials.gov registry entry for NCT06300450 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 119-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (236% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Computer Alert is the first listed.
NCT06300450 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06300450 about?
NCT06300450 is a clinical study titled "Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy". This single-center, 400-patient, randomized controlled trial assesses the impact of a patient- and provider-facing EPIC Best Practice Advisory (BPA; alert-based computerized decision support tool) to increase guideline-directed utilization of statin and statin-alternative oral LDL-C lowering therapi...
What is the current status of trial NCT06300450?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-03-01. Estimated completion is 2026-07-30.
What conditions does trial NCT06300450 study?
This clinical trial studies the following conditions: Peripheral Artery Disease, Dyslipidemias, Peripheral Vascular Diseases.
What interventions are being tested in trial NCT06300450?
The interventions under investigation include: Computer Alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT06300450?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06300450 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
-
Oxygen-guided Supervised Exercise Therapy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.